# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA438945 | hNPY | IC50 | = | 2.8 | 10'-11M | ALA3876376 | 10.55 | nM | Homo sapiens | ||
2. | ALA438945 | hNPY | IC50 | = | 2.1 | 10'-10M | ALA3876375 | 9.68 | nM | Homo sapiens | ||
3. | ALA438945 | hNPY | IC50 | = | 2.6 | nM | ALA2320849 | 8.59 | nM | Homo sapiens | ||
4. | ALA438945 | hNPY | t1/2 | = | 12 | min | ALA3090293 | hr | Homo sapiens | |||
5. | ALA438945 | hNPY | Activity | 0 | ALA3091138 | Dose-dependent effect | Homo sapiens | |||||
6. | ALA438945 | hNPY | t1/2 | = | 4.8 | hr | ALA3091136 | hr | Homo sapiens | |||
7. | ALA438945 | hNPY | Drug degradation | < | 50 | % | ALA3091134 | % | Homo sapiens | |||
8. | ALA438945 | hNPY | t1/2 | = | 0.3 | hr | ALA3091133 | hr | Homo sapiens | |||
9. | ALA438945 | hNPY | Stability | 0 | ALA3091132 | Unstable | % | Homo sapiens | ||||
10. | ALA438945 | hNPY | Activity | 0 | ALA3091137 | Dose-dependent effect | Homo sapiens | |||||
11. | ALA438945 | hNPY | Ki | = | 282 | nM | ALA2447702 | 6.55 | nM | Homo sapiens | ||
12. | ALA438945 | hNPY | Emax | = | 56 | % | ALA2447457 | % | Homo sapiens | |||
13. | ALA438945 | hNPY | Ki | = | 0.5 | nM | ALA2447455 | 9.30 | nM | Homo sapiens | ||
14. | ALA438945 | hNPY | Ki | = | 0.8 | nM | ALA2447454 | 9.10 | nM | Homo sapiens | ||
15. | ALA438945 | hNPY | Ki | = | 2.2 | nM | ALA2447453 | 8.66 | nM | Homo sapiens | ||
16. | ALA438945 | hNPY | EC50 | = | 417 | nM | ALA2447701 | 6.38 | nM | Homo sapiens | ||
17. | ALA438945 | hNPY | IC50 | = | 1.4 | 10'-10M | ALA2394945 | 9.85 | nM | Homo sapiens | ||
18. | ALA438945 | hNPY | IC50 | = | 1.9 | 10'-10M | ALA2394942 | 9.72 | nM | Homo sapiens | ||
19. | ALA438945 | hNPY | Ki | = | 9.6 | 10'-11M | ALA2394945 | 10.02 | nM | Homo sapiens | ||
20. | ALA438945 | hNPY | Ki | = | 7.6 | 10'-11M | ALA2394942 | 10.12 | nM | Homo sapiens |